ACR on Air
ACR on Air
About ACR on Air
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
“Rheumatology For All” is an organization with a global mission: To increase access to rheumatology care in under-resourced regions. They aim to create self-sustaining rheumatology training programs by funding the education of local physicians to become rheumatologists and provide educational programs for local physicians. Much of the organization’s work is done in developing nations throughout Africa. Today, we have founding member and member of the board of directors, Dr. Michele Meltzer as our guest, to discuss their mission, how it began, where “Rheumatology For All” is going, and how you can get involved in the great need to expand rheumatic care to these under-served countries.
This week we discuss what a biosimilar is, why they’re causing such controversy and why they’ve taken seven years, since the FDA approved Amgevita, to come to market. We review the evidence behind the safety and efficacy of these drugs, the data from switching from a bio-originator to a biosimilar, and how the approval of the drugs may lower the health care costs and improve access to these medications.
This week, we have the distinct privilege to interview Dr. Dan Kaster, “The Father of Autio inflammatory Diseases”. His discoveries have taught us a great deal about how the immune system works, both in health and disease. His work has contributed to finding effective treatments for conditions that previously caused significant suffering and early death. Discussions around the many autoinflammatory diseases for which he is famous are had in this episode, but we dive deeper, asking about the keys to his success as an investigator as well. Dr. Kastner shares with us formative experiences as a medical student, skills he’s acquired solving the myriad of challenges he’s faced and the global collaborations he’s forged over his long and legendary career.
This week, our guest is Assoc. Prof. Of Medicine in Rheumatology at Loma Linda Univ. And board certified from the American Board of Lifestyle Medicine and Chair of ACR’s Government Affairs Committee, Dr. Christina Downey. Dr. Downey discusses and shares with us how to counsel and provide small and practical steps for patients to improve their wellness as well as tips on staying healthy while juggling clinical practice, administrative responsibilities and family life. We’ll learn all about empathy: what it is, how to get it and why you want it. And finally, Dr. Downey shares with us her work in advocacy for her patients and what motivates her to continue that work and fighting burnout
In this episode, we take a deep dive into the life of a researcher. We’ve invited Dr. Jeffrey Sparks to share with us how he ended up as an R01 independent researcher. We’ll learn how the sausage is made, as they say, of a successful grant submission. Jeff will share with us how he became interested in research, the skills he gained along the way, how mentors were necessary for his success, and he explains the alphabet soup of NIH grants. He also discusses the 20 medals that he has hanging on the wall of his office.
Join us this week as we welcome American College of Rheumatology Master, Dr. Herbert S. Baraf who is the founder and, up until his retirement this year, managing partner of “Arthritis & Rheumatism Associates” (one of the largest private rheumatology practices in America). Today, Dr. Baraf shares with us why he went into private practice, the risks and benefits of doing so, and his invaluable lifetime experience for those looking to enter and those within private practice. Currently, Dr. Baraf is a Special Volunteer at National Institue of Arthritis and Musculoskeletal and Skin Diseases. He holds appts as Clinical Professor of Medicine at George Washington University and is an Associate Clinical Professor at The University of Maryland
This week we invited Dr. Stacy Ardoin, pediatric and adult rheumatologist, to discuss all the challenges of ushering children into adult care and (more importantly) how to facilitate the transition. Dr. Ardoin led the American College of Rheumatology’s participation in the American College of Physicians Pediatric to Adult Care Transition Toolkit Project and has published several research studies and reviews on the topic. Today, she offers her advice, processes at her own practice, and resources for both patient and parents to help your pediatric patient successfully navigate this critical period in their care.
Welcome to ACR Convergence 2022! Today, Dr. Vicki Shanmugam (host of ACR Journals on Air) joins Jon to tackle three, pivotal trials, that will be presented at our annual meeting this year! Join us as they dive into the objectives, the science behind them and their incredible results. You can find each one of the manuscripts discussed on this episode here: Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus Genicular Nerve Block for Pain Management in Patients With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial
ACR Convergence 2022 is almost here, and with that, new trials, new medications and new results. We’re preparing a very HOT episode for you, to be released along with the opening ceremony at ACR Convergence 2022, this Saturday, November 12th. In this preview of Saturday’s full episode, we’ve invited host of “ACR Journals on Air” Dr. Vicki Shanmugam, to briefly discuss all the exciting science that is just a few days away!
Excited for ACR Convergence 2022? So are we! This week Jon catches up with AMPC Chair, Dr. Sharon Kolasinski! It's been two years since we’ve gathered physically, and when we meet up at The Philadelphia Convention Center, you won’t be disappointed. Dr. Kolasinski dives into this year’s program, new features at Convergence and even the delicious dining to be had in this historic city of brotherly love. See you soon!
In this episode we discuss how pain syndromes occur, what's happening in the brain, how to diagnose and explain these syndromes in our patients and (most importantly) how to help patients on the road to recovery. Our guest, Dr. Schubiner, has decades of experience in treating patients with these syndromes and uses randomized controlled studies to inform his approach. These studies have shown that a specific type of treatment leads to a nearly complete elimination of pain in a large majority of patients with chronic pain. Psychophysiologic Disorders Association Non-profit professional organization and clearinghouse for information, lists of practitioners, bibliography of research articles, and an online training course The Tension Myositis Syndrome Wiki A peer-run support group organization for people looking for help with chronic pain, plus a list of practitioners, and online support groups UnlearnYourPain.com Six animated videos for educating patients on pain and the brain, plus lists of training programs, and other videos/lectures; and an online program for patients Stress Illness Recovery Practitioner’s Association A site in the UK with training & online programs Books written by our colleagues for patients: John Sarno—The Mindbody Prescription, Healing Back Pain, The Divided Mind Alan Gordon—The Way Out, pain reprocessing therapy for patients Howard Schubiner—Unlearn Your Pain and Unlearn Your Anxiety and Depression; books for patients with self-guided recovery programs Other books: David Hanscom—Back in Control and Should you have spine surgery? David Clarke—They can't find anything wrong David Schechter—Think away your pain Georgie Oldfield—The key to chronic pain recovery Books for professionals: Lisa Feldman Barrett—How Emotions are Made; on predictive processing Schubiner and Allan Abbass—Hidden from View PPD Association—Clarke, Schubiner, Abbass, Clark-Smith—Textbook on psychophysiologic disorders
During “The Great Debate” at ACR Convergence 2020, the question: “Should JAK inhibitors be started before TNF inhibitors in people with rheumatoid arthritis who failed methotrexate?” was asked. However, in 2021, results from the oral surveillance trial showed an increased risk of major adverse cardiovascular events in cancers among patients with rheumatoid arthritis taking tofacitinib as compared to those on TNF inhibitors. These findings led to the FDA updating their black box warning on JAK inhibitors. Today, we’ve invited one of the speakers on the great debate, Dr. Vibeke Strand, to speak on her position on JAK inhibitors given these new results and shed some more light on the subject.
Today, we’ve invited a clinical expert of spondyloarthritis, Dr. Maureen Dubreuil. In this episode, Dr. Dubreuil discusses how she evaluates and treats patients with this specific condition and shares with us tips and insights into how to diagnose and manage this disease.
This week’s episode is another installment of our popular “Hot Topics” series, where we discuss “must read” studies recently published in one of ACR’s three peer-reviewed journals. Joining us is Dr. Vicki Shanmugam. Not just our guest today, but also the host of a new ACR podcast series, “ACR Journals on Air” scheduled to launch later this summer. Today, we’ll hear what we can expect from her new podcast, and we’ll talk about some of her favorite studies in the ACR’s journals right now. Enjoy!
In this week’s episode, we discuss the "ACR’s 2022 Guideline Summary for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases" with lead author Dr. Anne Bass, Attending Physician in the Division of Rheumatology at Hospital for Special Surgery and a Professor of Clinical Medicine at Weill Cornell Medicine. During our conversation we consider the importance of guidelines for vaccines, the impact certain drugs like rituximab and methotrexate have on vaccinations, cover some vaccine highlights within the guidelines, how these guidelines can aid in navigation with insurance companies and much, much more.
Today we’re talking about implicit bias with Dr Arin Reeves. What bias is, how it permeates our lives, how it can negatively impact our workforce, and its impact on clinical research and patient care. Most importantly, we discuss what we can do about our implicit biases to prevent them from causing damage.
This week we welcome Dr. Alfred Kim to our show as we discuss B-Cell depleting therapies and how patients on these drugs may be more susceptible to COVID-19. During which, Dr. Kim takes us back to the beginning of the pandemic and how he and his patients initially managed the rituximab infusions, how and why people on this drug may be at increased risk of severe disease, the importance of vaccinations, and why they may not work for this patient population. Finally, we finish with Dr. Kim sharing with us important information on how to mitigate the risk of COVID-19 among people taking b-cell depleting therapies, now that there are new therapies for COVID-19 pre-exposure prophylaxis.
Today’s episode is all about mental health for today’s healthcare professionals with our guest, Dr. Hanna Zembrzuska. She is a psychiatrist and rheumatologist and is a clinical assistant professor at The University of Iowa, holding appointments in the depts of internal medicine and psychiatry. We discuss everything from what burnout is, strategies to prevent/overcome it, the importance of having a sense of control within your medical practice and how to establish boundaries to coaching and support groups for physicians, as well as tips and tricks to maintain your mental health during busy clinic days. We then dive into how depression and anxiety can cause physical pain with rheumatic disease.
Today, in this episode, we’ll discuss the new “2021 Guideline for the Management of Kawasaki Disease”, the mysterious triggers that cause KD, the use of therapies such as IVIG, steroids, infliximab, anakinra, and compare multisystem inflammatory disease in children, or MIS-C (a condition very similar to Kawasaki Disease that is triggered by SARS COV-2). Joining us today is Dr. Mark Gorelik, lead Author of the “2021 Guideline for the Management of Kawasaki Disease”. He’s an assistant professor of pediatrics at the Columbia University Vagelos College of Physicians and Surgeons, is a pediatric rheumatologist, an allergist and immunologist. His research focuses on vasculitis, including Kawasaki disease, and on immune dysregulation.
Health & Fitness
The podcast ACR on Air is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.